60 Degrees Pharmaceuticals provides investor presentation via RedChip webinar; no specific details disclosed

60 DEGREES PHARMACEUTICALS, INC.

Company made investor presentation available on January 8, 2026, in connection with RedChip webinar.
Presentation covers updated clinical development timelines and regulatory strategy (no details disclosed).
Filing includes standard forward-looking statement disclaimer; no financial guidance provided.
Presentation exhibit (Ex. 99.1) contains only cover page and disclaimer, not slide content.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.